CMCSA
42
-3
ADSK
47
-2
DNB
54
-2
VIX
71
5
ABT
65
3
DG
29
2
ABBV
37
-3
ACN
18
-2
CNP
65
-2
IP
45
-2
GOOG
42
-9
CF
41
3
AMP
63
9
CTSH
42
-3
CMG
43
-2
HCA
48
-3
EFX
55
-3
AAPL
48
-5
COF
53
-2
MS
55
-2
CMCSA
42
-3
ADSK
47
-2
DNB
54
-2
VIX
71
5
ABT
65
3
DG
29
2
ABBV
37
-3
ACN
18
-2
CNP
65
-2
IP
45
-2
GOOG
42
-9
CF
41
3
AMP
63
9
CTSH
42
-3
CMG
43
-2
HCA
48
-3
EFX
55
-3
AAPL
48
-5
COF
53
-2
MS
55
-2
Financhill
Back

abrdn Life Sciences Investors Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
33

HQL
abrdn Life Sciences Investors

Last Price:
$11.75
Seasonality Move:
2.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

abrdn Life Sciences Investors Stock Forecast

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 4.9% based on the past 27 years of stock performance.
  • abrdn Life Sciences Investors has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is abrdn Life Sciences Investors Stock Undervalued?
    The current abrdn Life Sciences Investors [HQL] share price is $11.66. The Score for HQL is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • HQL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will abrdn Life Sciences Investors Stock Go Up Next Year?

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 4.9% based on the past 27 years of stock performance.

abrdn Life Sciences Investors Stock Rating

Sell
33
abrdn Life Sciences Investors (HQL) is a Sell

Is abrdn Life Sciences Investors overpriced?

  • abrdn Life Sciences Investors has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

abrdn Life Sciences Investors Stock Price History

Is HQL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HQL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Sector:
Type:
stock
Website:
abrdnhql.com

52-Week Data

52-Week High:
15.90
52-Week Low:
10.55

Prediction Charts

Market Cap:
0
Price in USD:
11.66
Volume:
71.8K
Beta:
0.96

Technical Analysis

SMA50:
13.01
SMA100:
13.41
SMA200:
14.22
52-Wk Change:
-9.05%

Stock Predictions

  • Is abrdn Life Sciences Investors stock public?
    Yes, abrdn Life Sciences Investors is a publicly traded company.
  • What is the abrdn Life Sciences Investors stock quote today?
    The abrdn Life Sciences Investors stock price is 11.66 USD today.
  • How to buy abrdn Life Sciences Investors stock online?
    You can buy abrdn Life Sciences Investors shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-28 12.95 12.88 12.98 12.83
Mar-31 12.78 12.69 12.78 12.37
Apr-1 12.65 12.34 12.66 12.25
Apr-2 12.30 12.31 12.32 12.17
Apr-3 12.20 12.16 12.34 12.12
Apr-4 12.01 11.44 12.06 11.41
Apr-7 11.21 11.08 11.30 10.90
Apr-8 11.19 10.87 11.55 10.75
Apr-9 10.85 11.45 11.55 10.55
Apr-10 11.45 11.14 11.45 10.82
Apr-11 11.23 11.48 11.52 11.14
Apr-14 11.63 11.82 11.84 11.58
Apr-15 11.82 11.76 11.93 11.69
Apr-16 11.76 11.66 11.82 11.59

abrdn Life Sciences Investors Earnings

Data Unavailable

abrdn Life Sciences Investors Forecast Revenue Growth

Data Unavailable

* abrdn Life Sciences Investors stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.